1-235759221-G-C
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000081.4(LYST):c.6632C>G(p.Pro2211Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0002 in 1,614,112 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P2211P) has been classified as Likely benign.
Frequency
Consequence
NM_000081.4 missense
Scores
Clinical Significance
Conservation
Publications
- Chediak-Higashi syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P
- attenuated Chédiak-Higashi syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000081.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LYST | NM_000081.4 | MANE Select | c.6632C>G | p.Pro2211Arg | missense | Exon 23 of 53 | NP_000072.2 | ||
| LYST | NM_001301365.1 | c.6632C>G | p.Pro2211Arg | missense | Exon 23 of 53 | NP_001288294.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LYST | ENST00000389793.7 | TSL:5 MANE Select | c.6632C>G | p.Pro2211Arg | missense | Exon 23 of 53 | ENSP00000374443.2 | ||
| LYST | ENST00000489585.5 | TSL:1 | n.*466C>G | non_coding_transcript_exon | Exon 23 of 23 | ENSP00000513166.1 | |||
| LYST | ENST00000489585.5 | TSL:1 | n.*466C>G | 3_prime_UTR | Exon 23 of 23 | ENSP00000513166.1 |
Frequencies
GnomAD3 genomes AF: 0.00110 AC: 168AN: 152138Hom.: 2 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000215 AC: 54AN: 250946 AF XY: 0.000155 show subpopulations
GnomAD4 exome AF: 0.000106 AC: 155AN: 1461856Hom.: 1 Cov.: 33 AF XY: 0.000106 AC XY: 77AN XY: 727226 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00110 AC: 168AN: 152256Hom.: 2 Cov.: 32 AF XY: 0.00109 AC XY: 81AN XY: 74438 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:1
Variant summary: LYST c.6632C>G (p.Pro2211Arg) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00022 in 250946 control chromosomes, predominantly at a frequency of 0.0031 within the African or African-American subpopulation in the gnomAD database, including 1 homozygotes. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 3 fold of the estimated maximal expected allele frequency for a pathogenic variant in LYST causing Chediak-Higashi Syndrome phenotype (0.0011). To our knowledge, no occurrence of c.6632C>G in individuals affected with Chediak-Higashi Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 525190). Based on the evidence outlined above, the variant was classified as likely benign.
LYST-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Chédiak-Higashi syndrome Benign:1
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at